Selcia Essex, United Kingdom of Great Britain and Northern Ireland (the)

About Selcia:

Selcia is a global contract research provider of integrated drug discovery, medicinal chemistry and 14C radiolabeled compounds. Established in 2001, the company has two divisions: Selcia Drug Discovery - with medicinal chemistry, biology ADME, and a unique peptidyl proyl isomerase (PPIase) inhibitor screening platform; and Selcia Radiolabeling - one of the world’s largest suppliers of custom 14C radiochemicals.

Service Offerings:

• Medicinal Chemistry
• Assay Development
• PPLase Services
• 14C Custom Synthesis
• 14 C GMP Radiolabelled API for Clinical Trials
• ADME/PK
• Custom Synthesis
• GLP Analysis Including GLP NMR
• Carbon -14 API to GMP
• Stability Studies

Reviews: